Search

Your search keyword '"Frausini, G."' showing total 83 results

Search Constraints

Start Over You searched for: "Frausini, G." Remove constraint "Frausini, G."
83 results on '"Frausini, G."'

Search Results

1. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

2. Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases

3. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

4. Tocilizumab in COVID‐19 interstitial pneumonia.

5. Discharge from the emergency department and early hospital revaluation in patients with COVID-19 pneumonia: a prospective study.

6. The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry

7. The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry

8. The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry

9. Safety of intermediate dose of low molecular weight heparin in COVID-19 patients.

10. Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell.

11. High vs. low doses of low‐molecular‐weight heparin for the treatment of superficial vein thrombosis of the legs: a double‐blind, randomized trial

12. Aspirin for preventing the recurrence of venous thromboembolism

13. Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study.

14. Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis.

15. Aspirin for Preventing the Recurrence of Venous Thromboembolism

16. MEDICAL SCIENCE. GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction

19. DETERMINANTS OF 6-MONTH MORTALITY IN SURVIVORS OF MYOCARDIAL-INFARCTION AFTER THROMBOLYSIS - RESULTS OF THE GISSI-2 DATA-BASE

20. Mechanisms by Which SARS-CoV-2 Invades and Damages the Central Nervous System: Apart from the Immune Response and Inflammatory Storm, What Else Do We Know?

21. [Peripheral vascular damage in hypertension].

22. Diuresis and intensive saluresis.

23. [The treatment of refractory hyperlipoproteinemias].

24. [A large case load of patients with dyslipidemia: effects of treatment with deae-dextran].

25. Olfactory Disfunction and Co-ultraPEALut

26. Early Hospital Discharge Using Remote Monitoring for Patients Hospitalized for COVID-19, Regardless of Need for Home Oxygen Therapy: A Descriptive Study.

27. Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction.

28. [Cellular water-electrolyte equilibrium in edema and changes induced by diuretics].

30. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].

31. [Intensive saluresis].

32. [Hemodynamic effects of diuretics].

33. [Clinical program of therapy for ascitic edema in liver disease].

34. [Negative effects of diuretics].

35. [Diuretics in the therapy of arterial hypertension].

36. [Indications for therapy with diuretics].

37. [Diuretics].

38. [Physiopathology of the body fluids].

39. [Clinical pharmacology of vasoactive substances: study on pentoxifylline].

40. Low Molecular Weight Heparin, Anti-inflammatory/Immunoregulatory and Antiviral Effects, a Short Update.

41. Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?

42. Cross-Cultural Validation of the Short Version of the Questionnaire of Olfactory Disorders—Negative Statements into Italian: Towards Personalized Patient Care.

43. Impact of COVID-19 Pandemic on Management and Outcomes in Patients with Septic Shock in the Emergency Department.

44. Long-standing gustatory and olfactory dysfunction in COVID-19 patients: a prospective study.

45. Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke.

46. Asthma and Cacosmia Could Be Predictive Factors of Olfactory Dysfunction Persistence 9 Months after SARS-CoV-2 Infection: The ANOSVID Study.

47. Therapeutic strategies to fight COVID‐19: Which is the status artis?

48. Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis.

50. Medical Thermology 2020 - a literature survey with a focus on applications in the COVID 19 pandemic.

Catalog

Books, media, physical & digital resources